Correlation Between Eliem Therapeutics and ProMIS Neurosciences
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and ProMIS Neurosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and ProMIS Neurosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and ProMIS Neurosciences, you can compare the effects of market volatilities on Eliem Therapeutics and ProMIS Neurosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of ProMIS Neurosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and ProMIS Neurosciences.
Diversification Opportunities for Eliem Therapeutics and ProMIS Neurosciences
0.78 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Eliem and ProMIS is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and ProMIS Neurosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProMIS Neurosciences and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with ProMIS Neurosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProMIS Neurosciences has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and ProMIS Neurosciences go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and ProMIS Neurosciences
Given the investment horizon of 90 days Eliem Therapeutics is expected to generate 0.79 times more return on investment than ProMIS Neurosciences. However, Eliem Therapeutics is 1.26 times less risky than ProMIS Neurosciences. It trades about 0.03 of its potential returns per unit of risk. ProMIS Neurosciences is currently generating about 0.0 per unit of risk. If you would invest 285.00 in Eliem Therapeutics on September 3, 2024 and sell it today you would earn a total of 19.00 from holding Eliem Therapeutics or generate 6.67% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Eliem Therapeutics vs. ProMIS Neurosciences
Performance |
Timeline |
Eliem Therapeutics |
ProMIS Neurosciences |
Eliem Therapeutics and ProMIS Neurosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Eliem Therapeutics and ProMIS Neurosciences
The main advantage of trading using opposite Eliem Therapeutics and ProMIS Neurosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, ProMIS Neurosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProMIS Neurosciences will offset losses from the drop in ProMIS Neurosciences' long position.Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
ProMIS Neurosciences vs. biOasis Technologies | ProMIS Neurosciences vs. Zenith Capital Corp | ProMIS Neurosciences vs. Hemogenyx Pharmaceuticals Plc | ProMIS Neurosciences vs. Fennec Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |